GlassScriptPhysician profile
Benjamin Adison Hendy
NPI 1134515406
$7,345.32
in general payments reported to CMS, 2019-2025
9 companies · $1,693 in 2025
The $1,693 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,082 · 2020: $807 · 2021: $1,952 · 2022: $153 · 2023: $236 · 2024: $1,423 · 2025: $1,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,958 · Food and Beverage: $1,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,958.45 |
| Food and Beverage | $1,393.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,619.37 | 2021-2025 | Blueprint Patient Specific Instrumentation, Mako, Augment Injectable |
| Liberty Surgical INC. | $1,718.40 | 2019-2020 | |
| Sequoia Surgical, INC. | $1,200.00 | 2021 | |
| Cornerstone Medical Associates, INC. | $704.17 | 2023-2024 | |
| Arthrex, INC. | $527.01 | 2024 | |
| Smith+Nephew, INC. | $387.53 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Endobutton |
| Exactech, INC. | $123.02 | 2024 | |
| Catalyst Orthoscience | $51.04 | 2023 | R1 Reverse Total Shoulder, Archer 3d Software, Csr & R1 Reverse Total Shoulder Systems |
| Boston Scientific Corporation | $14.78 | 2025 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Hendy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.